Fora Capital, LLC Galapagos Nv Transaction History

Fora Capital, LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$52.17 - $70.2 $70,951 - $95,472	-1,360 Closed	0 $0
Q2 2021 Aug 16, 2021	SELL	$68.86 - $83.34 $65,692 - $79,506	-954 Reduced 41.23%	1,360 $94 Million
Q1 2021 May 17, 2021	BUY	$76.15 - $111.94 $176,211 - $259,029	2,314 New	2,314 $178 Million
Q2 2020 Aug 14, 2020	SELL	$185.52 - $231.25 $27,828 - $34,687	-150 Closed	0 $0
Q1 2020 May 15, 2020	BUY	$143.0 - $274.03 $21,450 - $41,104	150 New	150 $29,000

12.3M

69.1K

42.7K

Ticker GLPG
Exchange OTC
Sector Healthcare
Industry Biotechnology
Shares Outstandng 65,835,500
Market Cap $1.9B
Description
Galapagos NV, an integrated biopharmaceutical company, engages in the discovery, development, and commercialization of various medicines for high unmet medical need. Its pipeline products include filgotinib, a JAK1 inhibitor that is in various phases of clinical trials for the treatment of rheumatoid arthritis, Crohn's disease, ulcerative coliti...

Get notified when there are updates to the investment portfolio of Fora Capital, LLC, based on Form 13F filings with the SEC.

Stay updated on Fora Capital, LLC with notifications on news.